Molecular Mechanism of Avicennia Marina in Inhibiting Hepatitis C Virus Based on Network Pharmacology and Molecular Docking
April 2025
in “
Tropical Journal of Natural Product Research
”
Studysummary In this study, researchers using network pharmacology and molecular docking methods found that compounds from Avicennia Marina could inhibit hepatitis C virus infection by targeting key proteins such as AKT1 and TNF-α, showing potential for anti-HCV treatments.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer